MedTrace Logo

A Study to Evaluate the Efficacy and Safety of Rosuvastatin in Hypercholesterolemia.

NCT01982461 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2013-11-13

No results posted yet for this study

Summary

The objective of this trial is to assess the efficacy of reducing plasma low-density lipoprotein(LDL) cholesterol and safety in two different brand drugs, Roty F.C. Tablets 10mg and Crestor 10mg F.C. Tablets in hypercholesterolemia population.

Conditions

Interventions

DRUG

Rosuvastatin

10mg,once daily

DRUG

Crestor®

10mg,once daily

Sponsors & Collaborators

  • Pin Siang Medical Biotechnology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Yi-Jen Hung, M.D. · Tri-Service General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01982461 on ClinicalTrials.gov